These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28078047)

  • 1. Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells.
    Sosińska P; Baum E; Maćkowiak B; Staniszewski R; Jasinski T; Umezawa K; Bręborowicz A
    Am J Transl Res; 2016; 8(12):5756-5765. PubMed ID: 28078047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis.
    Breborowicz A; Wisniewska J; Polubinska A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
    Perit Dial Int; 1998; 18(4):382-6. PubMed ID: 10505559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts.
    Inokawa S; Watanabe T; Keino H; Sato Y; Hirakata A; Okada AA; Fukuda K; Fukushima A; Umezawa K
    Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):557-63. PubMed ID: 25519802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulodexide modulates the dialysate effect on the peritoneal mesothelium.
    Misian M; Baum E; Breborowicz A
    J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.
    Witowski J; Topley N; Jörres A; Liberek T; Coles GA; Williams JD
    Kidney Int; 1995 Jan; 47(1):282-93. PubMed ID: 7731159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
    Cardile V; Libra M; Caggia S; Frasca G; Umezawa K; Stivala F; Mazzarino MC; Bevelacqua Y; Coco M; Malaponte G
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):679-83. PubMed ID: 20337659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression.
    Li FK; Davenport A; Robson RL; Loetscher P; Rothlein R; Williams JD; Topley N
    Kidney Int; 1998 Dec; 54(6):2170-83. PubMed ID: 9853284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
    Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
    Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
    Sato M; Nakanishi K; Haga S; Fujiyoshi M; Baba M; Mino K; ; Niwa H; Yokoo H; Umezawa K; Ohmiya Y; Kamiyama T; Todo S; Taketomi A; Ozaki M
    Oncol Res; 2013; 21(6):333-43. PubMed ID: 25198663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells.
    Chan TM; Leung JK; Tsang RC; Liu ZH; Li LS; Yung S
    Kidney Int; 2003 Aug; 64(2):519-33. PubMed ID: 12846747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ.
    Umezawa K
    Biomed Pharmacother; 2011 Jul; 65(4):252-9. PubMed ID: 21723080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
    Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
    Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.
    Witowski J; Jörres A; Coles GA; Williams JD; Topley N
    Kidney Int; 1996 Oct; 50(4):1212-23. PubMed ID: 8887280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells.
    Breborowicz A; Rodela H; Karoń J; Martis L; Oreopoulos DG
    Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro.
    Breborowicz A; Wisniewska J; Moberly JB; Oreopoulos DG
    Am J Kidney Dis; 1999 Oct; 34(4):663-8. PubMed ID: 10516347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis.
    Yung S; Chen XR; Tsang RC; Zhang Q; Chan TM
    J Am Soc Nephrol; 2004 May; 15(5):1178-88. PubMed ID: 15100358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.
    Matsuo H; Tamura M; Kabashima N; Serino R; Tokunaga M; Shibata T; Matsumoto M; Aijima M; Oikawa S; Anai H; Nakashima Y
    Kidney Int; 2006 Feb; 69(4):736-46. PubMed ID: 16518329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Suzuki E; Umezawa K
    Biomed Pharmacother; 2006 Nov; 60(9):578-86. PubMed ID: 16978829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.